Product
Supplier
Encyclopedia
Inquiry
NAD500mg buy - large image1
NAD500mg buy - image1

NAD500mg

126 Inquiries

Unit Price: Get Latest Price
CAS No.:

53-84-9

Port:

SHENZHEN

Packaging:

500mg*10vials

Price valid (until):

2026-04-10

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Peptide

  • Product Details

  • Seller Information

  • Inquiry History

  • Description

      Product Detail  

    We are a comprehensive chemical enterprise integrating manufacturing, processing, and export, specializing in pharmaceutical intermediates and a wide range of industrial chemicals.

    Since our establishment, we have adhered to the principles of integrity, strict quality control, and customer-oriented service. Through stable product quality and professional support, we have earned strong recognition and long-term trust from customers around the world.

    Our company has built a highly experienced international sales team capable of delivering complete product solutions and providing efficient, one-stop professional services to global clients.

    With synthetic biology platform technology as our core, we continuously advance innovative research and development, focusing on the development and production of recombinant therapeutic peptides and proteins.

    Our product portfolio includes:

    * Innovative drugs and APIs
    * Pharmaceutical and green synthetic industrial enzymes
    * Functional peptides and protein products
    ECHEMI Editorial Reference
    NAD+ is a coenzyme composed of ribosylnicotinamide 5'-diphosphate coupled to adenosine 5'-phosphate by pyrophosphate linkage.
    Solid
    NAD zwitterion is a NAD. It has a role as a geroprotector. It derives from a deamido-NAD zwitterion. It is a conjugate base of a NAD(+).|A coenzyme composed of ribosylnicotinamide 5'-diphosphate coupled to adenosine 5'-phosphate by pyrophosphate linkage. It is found widely in nature and is involved in numerous enzymatic reactions in which it serves as an electron carrier by being alternately oxidized (NAD+) and reduced (NADH). (Dorland, 27th ed)|Nadide is a dinucleotide of adenine and nicotinamide. It has coenzyme activity in redox reactions and also acts as a donor of ADP-ribose moieties.

    Basic Info
    Product Name:

    NAD

    Other Name:

    Adenosine 5′-(trihydrogen diphosphate),P′→5′-ester with 3-(aminocarbonyl)-1-β-D-ribofuranosylpyridinium,inner salt;Pyridinium,3-carbamoyl-1-β-D-ribofuranosyl-,hydroxide,5′→5′-ester with adenosine 5′-(trihydrogen pyrophosphate),inner salt;Adenosine 5′-(trihydrogen diphosphate),P′→5′-ester with 3-(aminocarbonyl)-1-β-D-ribofuranosylpyridinium hydroxide,inner salt;Codehydrase I;Codehydrogenase I;Coenzyme I;Diphosphopyridine nucleotide;DPN;Cozymase I;NAD;Nadide;Nicotinamide-adenine dinucleotide;Oxidized diphosphopyridine nucleotide;Adenine-nicotinamide dinucleotide;NAD+;Enzopride;β-NAD;β-Diphosphopyridine nucleotide;β-Nicotinamide adenine dinucleotide;β-NAD+;NSC 20272;CO-I;β-Nicotinamide adenine dinucleotide hydrate;30429-30-2;159929-29-0;1083039-67-1;1354693-98-3

    CAS No.:

    53-84-9

    Molecular Formula:

    C21H27N7O14P2

    InChIKeys:

    InChIKey=BAWFJGJZGIEFAR-NNYOXOHSSA-N

    Molecular Weight:

    663.43

    Exact Mass:

    663.109131

    EC Number:

    200-184-4

    NSC Number:

    757121

    DSSTox ID:

    DTXSID2045236

    NCI Thesaurus Code:

    C87339

    HScode:

    29349990

    Categories:

    Other Chemical Drugs

    Characteristics
    PSA:

    321

    XLogP3:

    -1.29620

    Appearance:

    White Powder

    Melting Point:

    140-142 °C (decomp)

    Water Solubility:

    soluble in water at 50mg/ml

    Storage Conditions:

    2-8°C

    Specific rotation:

    D20 -31.5° (c = 1.2 in water)

    Collision Cross Section:

    226.7 Ų [M+H]+ [CCS Type: DT, Method: single field calibrated with Agilent tune mix (Agilent)]|227.5 Ų [M+H]+ [CCS Type: DT, Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)]|222.7 Ų [M+Na]+ [CCS Type: DT, Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)]|223.8 Ų [M-H]- [CCS Type: DT, Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)]|230.8 Ų [M+Na-2H]- [CCS Type: DT, Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)]|227 Ų [M+H]+ [CCS Type: TW, Method: calibrated with polyalanine and drug standards]

    Hazard Identification

    Classification of the substance or mixture

    Not classified.

    GHS label elements, including precautionary statements

    Pictogram(s) No symbol.
    Signal word

    No signal word

    Hazard statement(s)

    none

    Precautionary statement(s)
    Prevention

    none

    Response

    none

    Storage

    none

    Disposal

    none

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Peptide

    Location:

    3rd Floor, Room 323, Building 3, No. 87 West Jiancai Road, Changping District, Beijing

    Year of Establishment:

    2024

  • Inquiry History
    126 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    NAD

    1 KG Oct 26, 2026
    India

    NAD

    100 G Oct 21, 2026
    India

    NAD+

    20 G Sep 30, 2026
    United States

    NAD

    30 MT Sep 29, 2026
    United Arab Emirates

    NAD

    10 MT Sep 19, 2026
    Australia

    NAD

    50 PCS Sep 16, 2026
    United States

    NAD

    30 MG Sep 1, 2026
    Philippines

    NAD+

    15 KG Sep 1, 2026
    Philippines

    NAD+

    15 KG Aug 31, 2026
    United Kingdom

    NAD+ 500mg for IV therapy

    2 MG Aug 11, 2026
    United States

    NAD+

    1 G Aug 7, 2026
    United States

    NAD+ 500mg / 1000mg

    100 MG Aug 7, 2026
    United States

    NAD+

    1000 MG Aug 4, 2026
    South Africa

    Nad+

    10 MT Jul 27, 2026
    United States

    β-Nicotinamide adenine dinucleotide

    10 G Jul 16, 2026
    Poland

    Fenbendazole

    1 KG Jul 14, 2026
    United States

    NAD

    10 MT Jul 9, 2026
    United States

    NAD+ 500

    10000 MG Jul 2, 2026
    United States

    Beta-Nicotinamide adenine dinucleotide Nad+

    1 MG Jun 18, 2026
    Australia

    Nad

    10 MG Jun 16, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.